Allakos (ALLK) will discontinue further development of AK006

Go back to Allakos (ALLK) will discontinue further development of AK006

Allakos Inc. (ALLK) PT Lowered to $0.40 at Jefferies

January 27, 2025 12:56 PM EST

Jefferies analyst Kevin Strang lowered the price target on Allakos Inc. (NASDAQ: ALLK) to $0.40 (from $1.40) while maintaining a Hold rating.

The analyst comments "We didn't have high conviction heading into the event, as there was no clin evidence of mast cell inhibition... More